Skip to content

Clinical trials

Completed Parkinson Disease trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Parkinson Disease Status: Completed Country / region: China Clear all

92 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20052
20061
20081
20091
20104
20116
20126
20135
20152
20162
20177
20189
20197
20208
20219
20226
20237
20243
20253
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed92

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Ruijin Hospital5
Xuanwu Hospital, Beijing5
Boehringer Ingelheim4
Luye Pharma Group Ltd.4
Changhai Hospital3
GlaxoSmithKline3
H. Lundbeck A/S3
Jiangsu HengRui Medicine Co., Ltd.3
The First Affiliated Hospital with Nanjing Medical University3
Anhui Medical University2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Parkinson Disease92
Emergence Delirium2
Essential Tremor2
Multiple System Atrophy2
Dyskinesias1
Hypersensitivity1
Hypokinesia1
Movement Disorders1
Musculoskeletal Pain1
Neurodegenerative Diseases1

Trials

Showing 1 to 25 of 92. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.